> At a certain point, virtual molecules must give way to the real thing. > Using the newly identified pharmacophore as a new map, a drug company > or research lab will synthesize and test molecules in a lab environment > to analyze non-virtual reactions. However, in this project, all results > from the virtual screening will remain with the University of Oxford > and the NFCR. That is, the rights to the research results remain with > non-profit organizations that are dedicated to cancer research.